Menopausal HT does not increase risks for CVD, type 2 diabetes for middle-aged women

Menopausal hormone therapy does not affect risks for cardiovascular disease or type 2 diabetes, according to findings from a study of middle-aged postmenopausal women in South Korea published in Menopause.

“To our knowledge, this is the first nationwide population-based study that investigated the effects of menopausal HTon the risk of CVDs and type 2 diabetes among middle-aged postmenopausal women by considering the time-related bias,” Ji-Yeob Choi, PhD, associate professor in the department of biomedical sciences at Seoul National University Graduate School in South Korea, and colleagues wrote.

Read more from Healio about Menopausal HT does not increase risks for CVD, type 2 diabetes for middle-aged women